Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 10373119.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evidence is presented here that a subset of tumors instead initially grows by coopting existing host vessels. This coopted host vasculature does not immediately undergo angiogenesis to support the tumor but instead regresses, leading to a secondarily avascular tumor and massive tumor cell loss. Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. The expression patterns of the angiogenic antagonist angiopoietin-2 and of pro-angiogenic vascular endothelial growth factor (VEGF) suggest that these proteins may be critical regulators of this balance between vascular regression and growth.
Medical subject headings
- Endothelial Growth Factors
- Lymphokines
- Membrane Glycoproteins
- Neoplasms, Experimental
- Neovascularization, Pathologic
- Proteins